Prot #ATYR1923-C-004: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Project: Research project

Project Details

StatusActive
Effective start/end date10/31/22 → 10/31/25

Funding

  • Medpace Clinical Research LLC ((OE) Prot #ATYR1923-C-004 // (OE) Prot #ATYR1923-C-004)
  • aTyr Pharma, Inc. ((OE) Prot #ATYR1923-C-004 // (OE) Prot #ATYR1923-C-004)